MTHFD2 and breast carcinoma: Overexpression of MTHFD2 has been associated with poor prognosis in patients with breast cancer38, and knockdown of MTHFD2 in breast cancer cell lines reduced cell viability; increased apoptosis39; decreased migration, invasion, and metastasis40; and increased the expression of cancer stem cell markers40.